Pagenax®: Superior CST reduction vs. aflibercept1–3
Pagenax®: Superior CST reduction vs. aflibercept 1–3
HAWK and HARRIER: Pagenax® outperformed aflibercept with superior CST reductions at Weeks 16 and 48 #1,2
...
HAWK and HARRIER: Pagenax® outperformed aflibercept with superior CST reductions at Weeks 16 and 48 #1,2
...
C H , constant domain, heavy-chain; C L , constant domain, light-chain; Fab fragment , antigen-binding; kDa , kilo Dalton; V H , variable domain, heavy-chain; V...
§ Including urticaria, rash, pruritus, and...
OVERALL SURVIVAL (ITT) 1,2
KRYXANA + AI shows significantly longer overall survival vs placebo + AI 1,2
ITT: Superiority was established for overall survival. KRYXANA...
In nearly 25 years, 5-year survival rates have improved by less than 5% in metastatic breast cancer (mBC). CDK 4/6 inhibitors have changed the treatment paradigm for woemen with HR+/HER2- mBC, but none have been able to demonstrate a statistically...